NCOR1P3

Across TCGA pan-cancer cohorts, NCOR1P3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of NCOR1P3’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where NCOR1P3 RNA is repressed in tumor relative to normal tissue. In most cancer types NCOR1P3 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD, LIHC, and HNSC are the cancer types where NCOR1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NCOR1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	−0.070	.005	3	view →
LIHC	Female	All	+0.036	.041	2	view →
HNSC	All	II,III,IV	+0.036	.010	2	view →
KIRC	All	All	+0.012	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

NCOR1P3–STAD

Open the STAD breakdown →